Categories
Aurobindo Pharma Limited — Updates, 21-05-2026: Press Release
21-05-2026 · 08:43 pm
Aurobindo Pharma's Q4FY26 revenue rose 5.6% to INR 8,853 Cr, with Net Profit at INR 921 Cr. Strong European growth (30.2% YoY to INR 2,795 Cr) offset US decline. The company achieved 9 USFDA approvals and generated $35mn in free cashflows after a USD 317mn acquisition.
No comments yet. Be the first to comment!